Mechanisms involved in the development of adriamycin resistance in human leukemic cells

Leuk Res. 1990;14(6):567-73. doi: 10.1016/0145-2126(90)90009-x.

Abstract

We have developed three adriamycin (ADR)-resistant K562 sublines with different degrees of resistance. These sublines show a decreased accumulation and an increased efflux of ADR in proportion to the degree of resistance. Two membrane proteins (mol. wt 170,000 and 230,000) reactive with monoclonal antibody against P-glycoprotein were highly expressed in both the K562/ADR200 and the K562/ADR500 subline. Less resistant K562/ADR80 cells contained only small amounts of mol. wt 230,000 protein. Thus, the level of P-glycoprotein expression was not proportionate to the degree of ADR efflux. Verapamil treatment could not completely reverse ADR resistance. No significant change of glutathione-s-transferase activity nor in the level of DNA topoisomerase II was detected in resistant sublines. In our sublines it seems that P-glycoprotein is one of the mechanisms for resistance, but additional mechanisms may be involved.

MeSH terms

  • ATP Binding Cassette Transporter, Subfamily B, Member 1
  • Blotting, Western
  • Cell Division / drug effects
  • Cell Line
  • DNA Topoisomerases, Type I / analysis
  • Doxorubicin / pharmacokinetics*
  • Drug Resistance
  • Etoposide / pharmacology
  • Glutathione Transferase / biosynthesis
  • Humans
  • In Vitro Techniques
  • Leukemia, Myeloid / drug therapy*
  • Leukemia, Myeloid / immunology
  • Leukemia, Myeloid / metabolism
  • Membrane Glycoproteins / analysis
  • Verapamil / pharmacology
  • Vincristine / pharmacology

Substances

  • ATP Binding Cassette Transporter, Subfamily B, Member 1
  • Membrane Glycoproteins
  • Vincristine
  • Etoposide
  • Doxorubicin
  • Verapamil
  • Glutathione Transferase
  • DNA Topoisomerases, Type I